Wim van den Brink

Wim van den Brink's AcademicInfluence.com Rankings

Wim van den Brink

Biology

#4687

World Rank

#6971

Historical Rank

biology Degrees

Download Badge

Biology

Wim van den Brink's Degrees

Doctorate Medicine University of Amsterdam
PhD Psychiatry University of Amsterdam

Why Is Wim van den Brink Influential?

(Suggest an Edit or Addition)

According to Wikipedia, Wim van den Brink is emeritus Professor of Psychiatry and Addiction at the Academic Medical Center, University of Amsterdam. He was Director of the Amsterdam Institute for Addiction Research and Scientific Director of the National Committee for Treatment of Heroin Addiction in Utrecht, the Netherlands.

(See a Problem?)

Wim van den Brink's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

Dialectical behaviour therapy for women with borderline personality disorder (2003) (666)
Neurocognitive functions in pathological gambling: a comparison with alcohol dependence, Tourette syndrome and normal controls. (2006) (461)
Decision making in pathological gambling: a comparison between pathological gamblers, alcohol dependents, persons with Tourette syndrome, and normal controls. (2005) (437)
Prevalence of attention-deficit hyperactivity disorder in substance use disorder patients: a meta-analysis and meta-regression analysis. (2012) (403)
A three-pathway psychobiological model of craving for alcohol. (1999) (387)
Why gamblers fail to win: A review of cognitive and neuroimaging findings in pathological gambling (2010) (372)
Deep brain stimulation restores frontostriatal network activity in obsessive-compulsive disorder (2013) (360)
Gabapentin, opioids, and the risk of opioid-related death: A population-based nested case–control study (2017) (322)
Brain activation patterns associated with cue reactivity and craving in abstinent problem gamblers, heavy smokers and healthy controls: an fMRI study (2010) (311)
Medical prescription of heroin to treatment resistant heroin addicts: two randomised controlled trials (2003) (310)
WHO Study on the reliability and validity of the alcohol and drug use disorder instruments: overview of methods and results. (1997) (310)
Response Perseveration and Ventral Prefrontal Sensitivity to Reward and Punishment in Male Problem Gamblers and Smokers (2009) (310)
Pathological gambling: a comprehensive review of biobehavioral findings (2004) (309)
Cortisol Moderates the Relationship between Testosterone and Aggression in Delinquent Male Adolescents (2007) (299)
Extending the Treatment Options in Alcohol Dependence: A Randomized Controlled Study of As-Needed Nalmefene (2013) (293)
Attentional bias predicts heroin relapse following treatment. (2006) (286)
Effects of dose, sex, and long-term abstention from use on toxic effects of MDMA (ecstasy) on brain serotonin neurons (2001) (261)
Effects of non-invasive neurostimulation on craving: A meta-analysis (2013) (261)
Initial validation of two opiate craving questionnaires the obsessive compulsive drug use scale and the desires for drug questionnaire. (2002) (255)
Hyperresponsiveness of hypothalamic-pituitary-adrenal axis to combined dexamethasone/corticotropin-releasing hormone challenge in female borderline personality disorder subjects with a history of sustained childhood abuse (2002) (254)
Behavioral and neuroimaging evidence for overreliance on habit learning in alcohol-dependent patients (2013) (249)
Grey matter alterations associated with cannabis use: Results of a VBM study in heavy cannabis users and healthy controls (2012) (246)
The World Federation of ADHD International Consensus Statement: 208 Evidence-based conclusions about the disorder (2021) (242)
Sustained efficacy of dialectical behaviour therapy for borderline personality disorder. (2005) (241)
Dialectical Behavior Therapy of borderline patients with and without substance use problems. Implementation and long-term effects. (2002) (238)
The Relationship between Impulsive Choice and Impulsive Action: A Cross-Species Translational Study (2012) (220)
Instability of the ecstasy market and a new kid on the block: mephedrone (2011) (220)
Memory disturbances in ”Ecstasy” users are correlated with an altered brain serotonin neurotransmission (2000) (217)
Intrauterine cannabis exposure affects fetal growth trajectories: the Generation R Study. (2009) (213)
Substance use disorders and the orbitofrontal cortex: systematic review of behavioural decision-making and neuroimaging studies. (2005) (211)
A randomised, double-blind, placebo-controlled, efficacy study of nalmefene, as-needed use, in patients with alcohol dependence (2013) (210)
Deep brain stimulation in addiction: a review of potential brain targets (2012) (209)
The adverse health effects of synthetic cannabinoids with emphasis on psychosis-like effects (2015) (208)
Cortical serotonin transporter density and verbal memory in individuals who stopped using 3,4-methylenedioxymethamphetamine (MDMA or "ecstasy"): preliminary findings. (2001) (206)
Psychiatric Disorders in Detained Male Adolescents: A Systematic Literature Review (2010) (194)
The role of self-reported impulsivity and reward sensitivity versus neurocognitive measures of disinhibition and decision-making in the prediction of relapse in pathological gamblers (2007) (184)
Psychophysiological determinants and concomitants of deficient decision making in pathological gamblers. (2006) (182)
SSRI treatment of borderline personality disorder: a randomized, placebo-controlled clinical trial for female patients with borderline personality disorder. (2002) (181)
Personality disorders in alcoholics and drug addicts. (1993) (175)
Ranking the Harm of Alcohol, Tobacco and Illicit Drugs for the Individual and the Population (2010) (175)
Heroin on trial: Systematic review and meta-analysis of randomised trials of diamorphine-prescribing as treatment for refractory heroin addiction (2015) (174)
Compulsivity in obsessive–compulsive disorder and addictions (2016) (174)
Long-term effects of frequent cannabis use on working memory and attention: an fMRI study (2006) (170)
Alcohol use disorders in EU countries and Norway: An overview of the epidemiology (2005) (168)
Properties of the Hopkins Symptom Checklist-25 (HSCL-25) and the Self-Reporting Questionnaire (SRQ-20) as screening instruments used in primary care in Afghanistan (2007) (167)
Comorbidity and risk indicators for alcohol use disorders among persons with anxiety and/or depressive disorders: findings from the Netherlands Study of Depression and Anxiety (NESDA). (2011) (166)
Brain Imaging Studies in Pathological Gambling (2010) (165)
Effects of frequent cannabis use on hippocampal activity during an associative memory task (2007) (165)
Variability in the prevalence of adult ADHD in treatment seeking substance use disorder patients: Results from an international multi-center study exploring DSM-IV and DSM-5 criteria☆☆ (2013) (164)
Pharmacokinetics and pharmacokinetic variability of heroin and its metabolites: review of the literature. (2006) (160)
Psychiatric disorders in a representative sample of incarcerated boys in the Netherlands. (2004) (159)
A systematic review of the effectiveness of the community reinforcement approach in alcohol, cocaine and opioid addiction. (2004) (159)
Predicting the transition from frequent cannabis use to cannabis dependence: a three-year prospective study. (2013) (158)
Striatal Dopamine Transporter Availability Associated with Polymorphisms in the Dopamine Transporter Gene SLC6A3 (2008) (154)
Lower-Risk Cannabis Use Guidelines: A Comprehensive Update of Evidence and Recommendations (2017) (150)
Similar hyporesponsiveness of the dorsomedial prefrontal cortex in problem gamblers and heavy smokers during an inhibitory control task. (2012) (146)
Neural responses associated with cue‐reactivity in frequent cannabis users (2013) (144)
Psychiatric comorbidity in treatment-seeking substance use disorder patients with and without attention deficit hyperactivity disorder: results of the IASP study. (2014) (142)
A voxel-based morphometry study comparing problem gamblers, alcohol abusers, and healthy controls. (2012) (141)
Efficacy of As-Needed Nalmefene in Alcohol-Dependent Patients with at Least a High Drinking Risk Level: Results from a Subgroup Analysis of Two Randomized Controlled 6-Month Studies (2013) (140)
Neurophysiological evidence for abnormal cognitive processing of drug cues in heroin dependence (2003) (139)
Distorted Expectancy Coding in Problem Gambling: Is the Addictive in the Anticipation? (2012) (139)
Cost utility analysis of co-prescribed heroin compared with methadone maintenance treatment in heroin addicts in two randomised trials (2005) (135)
A transdiagnostic dimensional approach towards a neuropsychological assessment for addiction: an international Delphi consensus study (2018) (135)
Validity of the Adult ADHD Self-Report Scale (ASRS) as a screener for adult ADHD in treatment seeking substance use disorder patients. (2013) (133)
European rating of drug harms (2015) (132)
Recreational nitrous oxide use: Prevalence and risks. (2015) (131)
N-Acetylcysteine Normalizes Glutamate Levels in Cocaine-Dependent Patients: A Randomized Crossover Magnetic Resonance Spectroscopy Study (2012) (130)
Serotonergic blunting to meta-chlorophenylpiperazine (m-CPP) highly correlates with sustained childhood abuse in impulsive and autoaggressive female borderline patients (2000) (129)
Neurobiological substrates of cue-elicited craving and anhedonia in recently abstinent opioid-dependent males. (2009) (128)
Response Inhibition during Cue Reactivity in Problem Gamblers: An fMRI Study (2012) (124)
The role of dopamine in human addiction: from reward to motivated attention. (2005) (123)
Efficacy, tolerability, and safety of low-dose and high-dose baclofen in the treatment of alcohol dependence: A systematic review and meta-analysis (2018) (123)
Harm potential of magic mushroom use: a review. (2011) (123)
Comorbid psychopathology in adolescents and young adults treated for substance use disorders (2006) (119)
Suicide risk in placebo-controlled studies of major depression. (2001) (119)
Effect of baseline cannabis use and working‐memory network function on changes in cannabis use in heavy cannabis users: A prospective fMRI study (2014) (118)
Measurements in the Addictions for Triage and Evaluation (MATE): an instrument based on the World Health Organization family of international classifications. (2010) (118)
Effective Deep Brain Stimulation in Heroin Addiction: A Case Report with Complementary Intracranial Electroencephalogram (2012) (117)
The Misuse of Prescription Opioids: A Threat for Europe? (2015) (116)
Neurobiological substrate of smoking-related attentional bias (2011) (116)
Lower-Risk Cannabis Use Guidelines: A Comprehensive Update of Evidence and Recommendations. (2017) (114)
Alcohol use disorders and the course of depressive and anxiety disorders. (2012) (111)
Prevalence of Personality Disorders among Alcoholics and Drug Addicts: An Overview (1995) (111)
Prediction of relapse to frequent heroin use and the role of methadone prescription: an analysis of the Amsterdam Cohort Study among drug users. (2005) (109)
Personality disorders predict relapse in alcoholic patients. (1998) (109)
Efficacy and safety of high-dose baclofen for the treatment of alcohol dependence: A multicentre, randomised, double-blind controlled trial (2016) (107)
A systematic review of the effectiveness of naltrexone in the maintenance treatment of opioid and alcohol dependence (2006) (107)
Recovery of neurocognitive functions following sustained abstinence after substance dependence and implications for treatment. (2014) (107)
Long-term efficacy, tolerability and safety of nalmefene as-needed in patients with alcohol dependence: A 1-year, randomised controlled study (2014) (107)
Psychiatric comorbidity in treatment-seeking alcoholics: the role of childhood trauma and perceived parental dysfunction. (2004) (107)
Acamprosate and prevention of relapse in alcoholics (1997) (106)
Decision-making deficits in alcohol-dependent patients with and without comorbid personality disorder. (2006) (106)
Pregabalin and the Risk for Opioid-Related Death: A Nested CaseControl Study (2018) (105)
An increase in overdose mortality during the first 2 weeks after entering or re-entering methadone treatment in Amsterdam. (2002) (105)
Sustained effects of ecstasy on the human brain: a prospective neuroimaging study in novel users. (2008) (104)
The World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for the Biological Treatment of Substance Use and Related Disorders. Part 2: Opioid dependence (2011) (103)
Intrauterine cannabis exposure leads to more aggressive behavior and attention problems in 18-month-old girls. (2011) (103)
Striatal dopamine D2 receptor binding and dopamine release during cue-elicited craving in recently abstinent opiate-dependent males (2008) (102)
Evidence-Based Treatment of Opioid-Dependent Patients (2006) (102)
Cross-sectional and prospective relation of cannabis potency, dosing and smoking behaviour with cannabis dependence: an ecological study. (2014) (102)
Heroin-assisted treatment as a response to the public health problem of opiate dependence. (2002) (100)
Mental health differences between frequent cannabis users with and without dependence and the general population. (2013) (100)
Pharmacokinetics and pharmacodynamics of high doses of pharmaceutically prepared heroin, by intravenous or by inhalation route in opioid-dependent patients. (2006) (99)
Behavioural aspects of impulsivity in alcoholics with and without a cluster-B personality disorder. (2006) (99)
Trends in use and misuse of opioids in the Netherlands: a retrospective, multi-source database study. (2019) (98)
Predictors of acamprosate efficacy: results from a pooled analysis of seven European trials including 1485 alcohol-dependent patients (2005) (98)
Cue Exposure Therapy for the Treatment of Opiate Addiction: Results of a Randomized Controlled Clinical Trial (2007) (98)
Contingency Learning in Alcohol Dependence and Pathological Gambling: Learning and Unlearning Reward Contingencies (2014) (97)
Heroin-assisted Treatment (HAT) a Decade Later: A Brief Update on Science and Politics (2007) (96)
A role for dopamine in the processing of drug cues in heroin dependent patients (2004) (95)
Efficacy of N-Acetylcysteine in the Treatment of Nicotine Dependence: A Double-Blind Placebo-Controlled Pilot Study (2011) (92)
Individual differences in decision making and reward processing predict changes in cannabis use: a prospective functional magnetic resonance imaging study (2013) (91)
Mood disorders and serotonin transporter density in ecstasy users—the influence of long-term abstention, dose, and gender (2004) (91)
Detecting psychopathology in young adults: the Young Adult Self Report, the General Health Questionnaire and the Symptom Checklist as screening instruments (1992) (90)
Linking the pharmacological content of ecstasy tablets to the subjective experiences of drug users (2012) (90)
Demographic, emotional and social determinants of cannabis use in early pregnancy: the Generation R study. (2008) (88)
Cognition in novice ecstasy users with minimal exposure to other drugs: a prospective cohort study. (2007) (88)
Approach-Bias Predicts Development of Cannabis Problem Severity in Heavy Cannabis Users: Results from a Prospective FMRI Study (2012) (87)
International Consensus Statement on Screening, Diagnosis and Treatment of Substance Use Disorder Patients with Comorbid Attention Deficit/Hyperactivity Disorder (2018) (87)
Effects of Modafinil on Neural Correlates of Response Inhibition in Alcohol-Dependent Patients (2013) (85)
Neuroimaging findings with MDMA/ecstasy: technical aspects, conceptual issues and future prospects (2006) (85)
Treatment seeking adults with autism or ADHD and co-morbid substance use disorder: prevalence, risk factors and functional disability. (2010) (85)
A pilot evaluation of the safety and tolerability of repeat dose administration of long-acting injectable naltrexone (Vivitrex) in patients with alcohol dependence. (2004) (84)
Trauma, Dissociation, and Posttraumatic Stress Disorder in Female Borderline Patients With and Without Substance Abuse Problems (2003) (84)
Personality Characteristics of Adults With Autism Spectrum Disorders or Attention Deficit Hyperactivity Disorder With and Without Substance Use Disorders (2009) (83)
The effectiveness of anxiety treatment on alcohol-dependent patients with a comorbid phobic disorder: a randomized controlled trial. (2005) (83)
Evidenced-Based Treatment of Opioid-Depend ent Patients (2006) (83)
Measuring craving: an attempt to connect subjective craving with cue reactivity. (2006) (81)
Should there be both categorical and dimensional criteria for the substance use disorders in DSM-V? (2006) (80)
Evidence-based pharmacological treatment of substance use disorders and pathological gambling. (2012) (80)
Impulsivity in adult ADHD patients with and without cocaine dependence. (2013) (80)
CLINICAL STUDY: Predicting the effect of naltrexone and acamprosate in alcohol‐dependent patients using genetic indicators (2009) (80)
Use of amphetamine by recreational users of ecstasy (MDMA) is associated with reduced striatal dopamine transporter densities: a [123I]β-CIT SPECT study – preliminary report (2001) (79)
A Prospective Cohort Study on Sustained Effects of Low-Dose Ecstasy Use on the Brain in New Ecstasy Users (2007) (78)
Validation of self-reported cannabis dose and potency: an ecological study. (2013) (77)
Memory function and serotonin transporter promoter gene polymorphism in ecstasy (MDMA) users (2006) (76)
Validation of [123I]β-CIT SPECT to Assess Serotonin Transporters In Vivo in Humans: a Double-Blind, Placebo-Controlled, Crossover Study with the Selective Serotonin Reuptake Inhibitor Citalopram (2005) (75)
Assessment of Cognitive Brain Function in Ecstasy Users and Contributions of Other Drugs of Abuse: Results from an fMRI Study (2008) (74)
Baclofen for the treatment of alcohol use disorder: the Cagliari Statement. (2018) (73)
Dopamine D2/3 receptor availability and amphetamine-induced dopamine release in obesity (2014) (73)
'Legal highs' an inappropriate term for 'Novel Psychoactive Drugs' in drug prevention and scientific debate. (2013) (72)
Dimensions and disorder specificity of impulsivity in pathological gambling. (2014) (72)
Pharmacokinetics of methadone and its primary metabolite in 20 opiate addicts (2004) (72)
Sustained-release dexamfetamine in the treatment of chronic cocaine-dependent patients on heroin-assisted treatment: a randomised, double-blind, placebo-controlled trial (2016) (70)
Right on Cue? Striatal Reactivity in Problem Gamblers (2012) (69)
Pharmacological treatments for heroin and cocaine addiction (2003) (69)
Population Pharmacokinetics of Heroin and its Major Metabolites (2006) (68)
Heroin-assisted treatment in the Netherlands: History, findings, and international context (2010) (68)
Effect of cannabis use on the course of schizophrenia in male patients: A prospective cohort study (2012) (67)
Validity of the EQ-5D as a generic health outcome instrument in a heroin-dependent population. (2006) (67)
Modafinil Modulates Resting-State Functional Network Connectivity and Cognitive Control in Alcohol-Dependent Patients (2013) (67)
Incentive Processing in Persistent Disruptive Behavior and Psychopathic Traits: A Functional Magnetic Resonance Imaging Study in Adolescents (2015) (67)
Predictors of the 2-year recurrence and persistence of alcohol dependence. (2012) (67)
Short-term efficacy of tricyclic antidepressants revisited: a meta-analytic study (2001) (66)
Facilitators and barriers in treatment seeking for cannabis dependence. (2013) (66)
Agreement between Maternal Cannabis Use during Pregnancy according to Self-Report and Urinalysis in a Population-Based Cohort: The Generation R Study (2010) (65)
High fat/carbohydrate ratio but not total energy intake induces lower striatal dopamine D2/3 receptor availability in diet-induced obesity (2013) (65)
Nalmefene for the management of alcohol dependence: review on its pharmacology, mechanism of action and meta-analysis on its clinical efficacy (2016) (64)
Outcome of long-term heroin-assisted treatment offered to chronic, treatment-resistant heroin addicts in the Netherlands. (2010) (64)
Reduced-risk drinking as a viable treatment goal in problematic alcohol use and alcohol dependence. (2013) (64)
Investigating the structure of craving using structural equation modeling in analysis of the obsessive-compulsive drinking scale: a multinational study. (2005) (64)
Ecstasy use and self-reported depression, impulsivity, and sensation seeking: a prospective cohort study (2006) (63)
Medical Co-Prescription of Heroin to Chronic, Treatment-Resistant Methadone Patients in the Netherlands (1999) (63)
Prefrontal N-acetylaspartate is strongly associated with memory performance in (abstinent) ecstasy users: preliminary report (2001) (63)
Evidence-based pharmacological treatment of substance use disorders and pathological gambling. (2012) (63)
Fear conditioning, persistence of disruptive behavior and psychopathic traits: an fMRI study (2013) (62)
The three year course of alcohol use disorders in the general population: DSM-IV, ICD-10 and the Craving Withdrawal Model. (2006) (62)
Does psychosocial treatment enhance the efficacy of acamprosate in patients with alcohol problems? (2002) (61)
The effect of naltrexone and acamprosate on cue-induced craving, autonomic nervous system and neuroendocrine reactions to alcohol-related cues in alcoholics (2007) (59)
Origin of the Comorbidity of Anxiety Disorders and Alcohol Dependence: Findings of a General Population Study (2006) (59)
Fluvoxamine Reduces Responsiveness of HPA Axis in Adult Female BPD Patients with a History of Sustained Childhood Abuse (2003) (59)
Specific effects of ecstasy and other illicit drugs on cognition in poly-substance users (2007) (59)
The nicotinic acetylcholine receptor partial agonist varenicline and the treatment of drug dependence: A review (2010) (59)
Heavy alcohol use, rather than alcohol dependence, is associated with dysregulation of the hypothalamic-pituitary-adrenal axis and the autonomic nervous system. (2011) (59)
Reliability and validity of the Marijuana Motives Measure among young adult frequent cannabis users and associations with cannabis dependence. (2015) (59)
The International ADHD in Substance Use Disorders Prevalence (IASP) study: background, methods and study population (2013) (58)
The Netherlands XTC Toxicity (NeXT) study: objectives and methods of a study investigating causality, course, and clinical relevance (2005) (58)
Trauma and dissociation in treatment-seeking alcoholics: towards a resolution of inconsistent findings. (2002) (57)
Being impulsive and obese increases susceptibility to speeded detection of high-calorie foods. (2015) (57)
Generic legislation of new psychoactive drugs (2013) (57)
Improving the EFQM Model: An empirical study on model development and theory building using concept mapping (2001) (56)
Electroencephalographic Power and Coherence Analyses Suggest Altered Brain Function in Abstinent Male Heroin-Dependent Patients (2004) (56)
Grey Matter Changes Associated with Heavy Cannabis Use: A Longitudinal sMRI Study (2016) (55)
Alcohol-use disorder severity predicts first-incidence of depressive disorders (2011) (55)
Heroin self-administration by means of ‘chasing the dragon’: pharmacodynamics and bioavailability of inhaled heroin (2001) (54)
Response to tricyclic antidepressants: independent of gender? (2004) (54)
Cue Reactivity Is Associated with Duration and Severity of Alcohol Dependence: An fMRI Study (2014) (54)
Paradoxes of gambling behaviour (1992) (53)
The relationship between impulsivity and craving in alcohol dependent patients (2013) (53)
The COMT val 158 met polymorphism and brain morphometry in healthy young adults (2006) (53)
Investigating the potential neurotoxicity of Ecstasy (MDMA): an imaging approach (2001) (52)
Neurophysiological effects of modafinil on cue-exposure in cocaine dependence: a randomized placebo-controlled cross-over study using pharmacological fMRI. (2013) (51)
Increased release of dopamine in the striata of young adults with hearing impairment and its relevance for the social defeat hypothesis of schizophrenia. (2014) (51)
Substance Use, Substance Use Disorders, and Comorbidity Patterns in a Representative Sample of Incarcerated Male Dutch Adolescents (2003) (51)
The ability of YSR scales to predict DSM/DISC–C psychiatric disorders among incarcerated male adolescents (2006) (51)
First contact incidence of psychotic disorders among native Dutch and Moroccan immigrants in the Netherlands: Influence of diagnostic bias (2010) (51)
Relationship between working‐memory network function and substance use: a 3‐year longitudinal fMRI study in heavy cannabis users and controls (2014) (50)
Differential relations between juvenile psychopathic traits and resting state network connectivity (2015) (50)
Depressive and anxiety disorders predicting first incidence of alcohol use disorders: results of the Netherlands Study of Depression and Anxiety (NESDA). (2013) (50)
The Use of Baclofen as a Treatment for Alcohol Use Disorder: A Clinical Practice Perspective (2019) (49)
Effect of Olanzapine and Risperidone on Subjective Well-Being and Craving for Cannabis in Patients with Schizophrenia or Related Disorders: A Double-Blind Randomized Controlled Trial (2008) (49)
Substance abuse and personality disorders (1997) (48)
Comorbid attention deficit hyperactivity disorder and substance use disorder complexity and chronicity in treatment-seeking adults. (2015) (48)
Response inhibition in alcohol-dependent patients and patients with depression/anxiety: a functional magnetic resonance imaging study (2013) (47)
Substance abuse in borderline personality disorder: clinical and etiological correlates. (2001) (47)
The performance of the Alcohol Use Disorder Identification Test (AUDIT) in detecting alcohol abuse and dependence in a population of depressed or anxious persons. (2010) (47)
The association between neighborhood disorder, social cohesion and hazardous alcohol use: a national multilevel study. (2012) (47)
From Symptoms to Neurobiology: Pathological Gambling in the Light of the New Classification in DSM-5 (2014) (47)
Effect of modafinil on impulsivity and relapse in alcohol dependent patients: A randomized, placebo-controlled trial (2013) (47)
Incidental use of ecstasy: no evidence for harmful effects on cognitive brain function in a prospective fMRI study (2007) (47)
Lower-Risk Cannabis Use Guidelines (LRCUG) for reducing health harms from non-medical cannabis use: A comprehensive evidence and recommendations update. (2021) (46)
Magnitude of effect of lithium in short-term efficacy studies of moderate to severe manic episode. (2007) (46)
Long-term treatment with the dopamine agonist quinagolide of patients with clinically non-functioning pituitary adenoma. (2000) (46)
Chasing the dragon, related to the impaired lung function among heroin users. (2002) (46)
Free‐Choice and No‐Choice High‐Fat Diets Affect Striatal Dopamine D2/3 Receptor Availability, Caloric Intake, and Adiposity (2012) (46)
Loss of brain graph network efficiency in alcohol dependence (2017) (46)
Neural substrates of impulsive decision making modulated by modafinil in alcohol-dependent patients (2014) (46)
The role of negative emotionality and impulsivity in depressive/anxiety disorders and alcohol dependence (2012) (46)
Two new neurophysiological indices of cocaine craving: evoked brain potentials and cue modulated startle reflex (2004) (45)
Matching of treatment-resistant heroin-dependent patients to medical prescription of heroin or oral methadone treatment: results from two randomized controlled trials. (2005) (45)
Defining Compulsive Behavior (2019) (45)
Obsessive-Compulsive Symptoms in a Randomized, Double-Blind Study With Olanzapine or Risperidone in Young Patients With Early Psychosis (2008) (44)
Efficacy and safety of sodium oxybate in alcohol‐dependent patients with a very high drinking risk level (2018) (44)
Efficacy of contingency management for cocaine dependence treatment: a review of the evidence. (2012) (44)
The Role of Different Aspects of Impulsivity as Independent Risk Factors for Substance Use Disorders in Patients with ADHD: A Review. (2015) (43)
The effect of sampling, diagnostic criteria and assessment procedures on the observed prevalence of DSM-III-R personality disorders among treated alcoholics. (1998) (43)
A prospective study on intrauterine cannabis exposure and fetal blood flow. (2010) (43)
Reduced-risk drinking as a viable treatment goal in problematic alcohol use and alcohol dependence. (2013) (42)
Smoking and the risk for bipolar disorder: evidence from a bidirectional Mendelian randomisation study (2019) (42)
The Dutch Cannabis Dependence (CanDep) study on the course of frequent cannabis use and dependence: objectives, methods and sample characteristics (2011) (42)
Pharmacokinetic and Pharmacodynamic Study of the Concomitant Administration of Methadone and TMC125 in HIV‐Negative Volunteers (2008) (42)
Adolescence, schizophrenia and drug abuse: a window of vulnerability (2005) (42)
Do comorbid anxiety disorders in alcohol-dependent patients need specific treatment to prevent relapse? (2003) (42)
The need for culture sensitive diagnostic procedures (2008) (42)
Using concept mapping to design an indicator framework for addiction treatment centres. (2005) (41)
Deep brain stimulation increases impulsivity in two patients with obsessive–compulsive disorder (2011) (41)
Resting state connectivity in alcohol dependent patients and the effect of repetitive transcranial magnetic stimulation (2015) (41)
The association between cingulate cortex glutamate concentration and delay discounting is mediated by resting state functional connectivity (2012) (40)
Potential influence of socioeconomic status on genetic correlations between alcohol consumption measures and mental health (2019) (40)
Treatment Seeking for Alcohol Use Disorders: Treatment Gap or Adequate Self-Selection? (2016) (40)
Coping styles in substance use disorder (SUD) patients with and without co-occurring attention deficit/hyperactivity disorder (ADHD) or autism spectrum disorder (ASD) (2015) (39)
Alcohol consumption and symptoms as predictors for relapse of DSM-5 alcohol use disorder. (2014) (39)
Development of pharmaceutical heroin preparations for medical co-prescription to opioid dependent patients. (2005) (39)
Risk behaviours among substance use disorder treatment seekers with and without adult ADHD symptoms. (2014) (39)
Psychopathic traits in adolescents are associated with higher structural connectivity (2015) (39)
Allocation of substance use disorder patients to appropriate levels of care: feasibility of matching guidelines in routine practice in Dutch treatment centres. (2007) (39)
Prevalence and construct validity of compulsive buying disorder in shopping mall visitors (2015) (39)
Interactions between Affective and Cognitive Processing Systems in Problematic Gamblers: A Functional Connectivity Study (2012) (38)
Age at onset of non-affective psychosis in relation to cannabis use, other drug use and gender (2012) (38)
Reduced Frontal Brain Volume in Non-Treatment-Seeking Cocaine-Dependent Individuals: Exploring the Role of Impulsivity, Depression, and Smoking (2014) (38)
Addressing the stimulant treatment gap: A call to investigate the therapeutic benefits potential of cannabinoids for crack-cocaine use. (2015) (37)
The role of conduct disorder in the association between ADHD and alcohol use (disorder). Results from the Netherlands Mental Health Survey and Incidence Study-2. (2012) (37)
Investigating the efficacy of integrated cognitive behavioral therapy for adult treatment seeking substance use disorder patients with comorbid ADHD: study protocol of a randomized controlled trial (2013) (37)
Treatment of crack-cocaine dependence with topiramate: a randomized controlled feasibility trial in The Netherlands. (2014) (37)
Reliability and validity of the Severity of Dependence Scale for detecting cannabis dependence in frequent cannabis users (2013) (37)
Association Between Smoking Behavior and Cognitive Functioning in Patients With Psychosis, Siblings, and Healthy Control Subjects: Results From a Prospective 6-Year Follow-Up Study. (2018) (36)
ICD-11 Gaming Disorder: Needed and just in time or dangerous and much too early? (2017) (36)
White matter alterations in cocaine users are negatively related to the number of additionally (ab)used substances (2017) (35)
Innovations in agonist maintenance treatment of opioid-dependent patients (2006) (35)
Craving and Withdrawal as Core Symptoms of Alcohol Dependence (2004) (35)
Everyday life consequences of substance use in adult patients with a substance use disorder (SUD) and co-occurring attention deficit/hyperactivity disorder (ADHD) or autism spectrum disorder (ASD): a patient’s perspective (2014) (35)
Predicting self-damaging and suicidal behaviors in female borderline patients: reasons for living, coping, and depressive personality disorder. (2001) (35)
Using the Autism-Spectrum Quotient to Discriminate Autism Spectrum Disorder from ADHD in Adult Patients With and Without Comorbid Substance Use Disorder (2009) (35)
Psychotic symptoms among male adolescent detainees in The Netherlands. (2004) (34)
Screening for Substance Abuse Among Adolescents Validity of the CAGE-AID in Youth Mental Health Care (2009) (34)
Interpersonal Aspects of DSM-III Axis II: Theoretical Hypotheses and Empirical Findings (1989) (34)
Neurotoxic effects of ecstasy on the thalamus (2008) (34)
Medical prescription of heroin to treatment resistant heroin addicts: two randomised controlled trials (2003) (34)
Experiences with an Outpatient Relapse Program (Community Reinforcement Approach) Combined with Naltrexone in the Treatment of Opioid-Dependence: Effect on Addictive Behaviors and the Predictive Value of Psychiatric Comorbidity (2003) (34)
GHB, GBL and 1,4-BD addiction. (2014) (34)
Incidence and prevalence of “diagnosed OCD” in a primary care, treatment seeking, population (2012) (34)
Patterns of acquisitive crime during methadone maintenance treatment among patients eligible for heroin assisted treatment. (2007) (33)
Sociodemographic and substance use characteristics of γ hydroxybutyrate (GHB) dependent inpatients and associations with dependence severity. (2013) (33)
The Role of Habits and Motivation in Human Drug Addiction: A Reflection (2014) (33)
Causal Factors of Increased Smoking in ADHD: A Systematic Review (2018) (32)
Assessment of lifetime physical and sexual abuse in treated alcoholics. Validity of the Addiction Severity Index. (2003) (32)
Relationship between trait impulsivity and cortical volume, thickness and surface area in male cocaine users and non-drug using controls. (2014) (32)
Static and Dynamic Patient Characteristics as Predictors of Criminal Recidivism: A Prospective Study in a Dutch Forensic Psychiatric Sample (2006) (32)
Predicting persistency of DSM-5 alcohol use disorder and examining drinking patterns of recently remitted individuals: a prospective general population study. (2013) (32)
Alcohol abuse and dependence criteria as predictors of a chronic course of alcohol use disorders in the general population. (2005) (32)
Regional grey matter volume and concentration in at-risk adolescents: Untangling associations with callous-unemotional traits and conduct disorder symptoms (2016) (32)
Longitudinal study of hippocampal volumes in heavy cannabis users (2017) (32)
The relationship between excessive alcohol consumption and alcohol use disorders according to DSM-IV and DSM-5. (2014) (32)
Age of onset and neuropsychological functioning in alcohol dependent inpatients. (2013) (32)
Suicide risk in placebo vs active treatment in placebo-controlled trials for schizophrenia. (2003) (31)
Pharmacological treatments for heroin and cocaine addiction. (2003) (31)
Effect of extended-release naltrexone on striatal dopamine transporter availability, depression and anhedonia in heroin-dependent patients (2015) (31)
Serotonin and dopamine transporters in relation to neuropsychological functioning, personality traits and mood in young adult healthy subjects (2010) (31)
Persistence and desistance in heavy cannabis use: the role of identity, agency, and life events (2015) (31)
Temporal stability of pathological scratchcard gambling among adult scratchcard buyers two years later. (2004) (31)
The relation between gray matter volume and the use of alcohol, tobacco, cocaine and cannabis in male polysubstance users. (2018) (31)
Co-occurrence of obsessive-compulsive disorder and substance use disorder in the general population. (2011) (31)
Measuring change with the General Health Questionnaire (GHQ) (1989) (31)
How to find future ecstasy-users: targeted and snowball sampling in an ethically sensitive context. (2007) (31)
Persistence and Subtype Stability of ADHD Among Substance Use Disorder Treatment Seekers (2019) (31)
Incidental Head and Neck Findings on MRI in Young Healthy Volunteers: Prevalence and Clinical Implications (2012) (30)
Reduced striatal brain volumes in non-medicated adult ADHD patients with comorbid cocaine dependence. (2013) (30)
Substrates of neuropsychological functioning in stimulant dependence: a review of functional neuroimaging research (2012) (30)
Decision making as a predictor of first ecstasy use: a prospective study (2008) (30)
Genetic correlates of socio-economic status influence the pattern of shared heritability across mental health traits (2020) (29)
Brain volume in male patients with recent onset schizophrenia with and without cannabis use disorders. (2015) (29)
Genetic and environmental influences on the relationship between adult ADHD symptoms and self-reported problem drinking in 6024 Dutch twins (2014) (28)
Dysfunctional amygdala activation and connectivity with the prefrontal cortex in current cocaine users (2015) (28)
Craving despite extremely high methadone dosage. (1996) (28)
Is Europe facing an opioid crisis like the United States? An analysis of opioid use and related adverse effects in 19 European countries between 2010 and 2018 (2021) (28)
Contact allergy and respiratory/mucosal complaints from heroin (diacetylmorphine) (2006) (28)
Is Europe Facing an Emerging Opioid Crisis Comparable to the U.S.? (2020) (28)
Temperament and character as endophenotype in adults with autism spectrum disorders or attention deficit/hyperactivity disorder (2015) (28)
Comorbid phobic disorders do not influence outcome of alcohol dependence treatment. Results of a naturalistic follow-up study. (2006) (28)
Are scratchcards addictive? The prevalence of pathological scratchcard gambling among adult scratchcard buyers in the Netherlands. (2003) (28)
Integrated cognitive behavioral therapy for ADHD in adult substance use disorder patients: Results of a randomized clinical trial. (2019) (28)
Antisocial alcoholic patients show as much improvement at 14-month follow-up as non-antisocial alcoholic patients. (1999) (27)
Brain function during cognitive flexibility and white matter integrity in alcohol‐dependent patients, problematic drinkers and healthy controls (2015) (27)
Pharmacokinetic Interactions Between Darunavir/Ritonavir and Opioid Maintenance Therapy Using Methadone or Buprenorphine/Naloxone (2011) (27)
Impact of DSM-5 changes on the diagnosis and acute treatment of schizophrenia. (2015) (27)
Development and validation of the Amsterdam Motives for Drinking Scale (AMDS): an attempt to distinguish relief and reward drinkers. (2006) (26)
Physical harm due to chronic substance use. (2013) (26)
Psychosocial work conditions and work stress in an innovating addiction treatment centre. Consequences for the EFQM Excellence Model (2009) (26)
Alcohol-dependent patients with comorbid phobic disorders: a comparison between comorbid patients, pure alcohol-dependent and pure phobic patients. (2004) (26)
Smoking, symptoms, and quality of life in patients with psychosis, siblings, and healthy controls: a prospective, longitudinal cohort study. (2019) (26)
Physiological and endocrine reactions to psychosocial stress in alcohol use disorders: duration of abstinence matters. (2013) (26)
Family history of alcohol dependence and gray matter abnormalities in non-alcoholic adults (2013) (26)
Cannabis Dependence and Peer Selection in Social Networks of Frequent Users (2011) (25)
Dialectical behaviour therapy for women Dialectical behaviour therapy for women with borderline personality disorder with borderline personality disorder 12-month, randomised clinical trial inThe Netherlands 12-month, randomised clinical trial inThe Netherlands (2003) (25)
BRIEF REPORT: Varenicline increases striatal dopamine D2/3 receptor binding in rats (2009) (25)
Cocaine Addiction Treatments to improve Control and reduce Harm (CATCH): New Pharmacological Treatment Options for Crack-Cocaine Dependence in the Netherlands (2011) (25)
The craving withdrawal model for alcoholism: towards the DSM-V. Improving the discriminant validity of alcohol use disorder diagnosis. (2005) (25)
Childhood trauma exposure in substance use disorder patients with and without ADHD. (2017) (25)
Personality as a risk factor for illicit opioid use and a protective factor for illicit opioid dependence. (2014) (25)
Intoxicated aggression: Do alcohol and stimulants cause dose-related aggression? A review (2020) (24)
Integrated cognitive behavioral therapy for patients with substance use disorder and comorbid ADHD: two case presentations. (2015) (24)
Craving and illicit heroin use among patients in heroin-assisted treatment. (2012) (24)
International Consensus Statement for the Screening, Diagnosis, and Treatment of Adolescents with Concurrent Attention-Deficit/Hyperactivity Disorder and Substance Use Disorder (2020) (24)
Triple monoamine inhibitor tesofensine decreases food intake, body weight, and striatal dopamine D2/D3 receptor availability in diet-induced obese rats (2012) (24)
Population pharmacokinetics of caffeine and its metabolites theobromine, paraxanthine and theophylline after inhalation in combination with diacetylmorphine. (2005) (23)
The two-faceted nature of impulsivity in patients with borderline personality disorder and substance use disorder. (2016) (23)
Estimating the number of opiate users in Amsterdam by capture–recapture: The importance of case definition (2004) (23)
Psychedelics for the treatment of depression, anxiety, and existential distress in patients with a terminal illness: a systematic review (2021) (23)
Management of opioid dependence (2003) (23)
A new nomenclature for classifying psychotropic drugs. (2017) (23)
Feasibility and validity of low-budget telephonic follow-up interviews in routine outcome monitoring of substance abuse treatment. (2009) (23)
Dose-dependent and sustained effects of varenicline on dopamine D2/3 receptor availability in rats (2011) (23)
Dopaminergic dysfunction in abstinent dexamphetamine users: results from a pharmacological fMRI study using a reward anticipation task and a methylphenidate challenge. (2013) (22)
Low dopamine transporter occupancy by methylphenidate as a possible reason for reduced treatment effectiveness in ADHD patients with cocaine dependence (2013) (22)
Long-term neuropsychological effects of ecstasy in middle-aged ecstasy/polydrug users (2009) (22)
Enhanced striatal responses during expectancy coding in alcohol dependence. (2014) (22)
A confirmatory analysis of the hierarchical structure of positive and negative dose-related alcohol expectancies in alcoholics and the associations with family history of alcoholism. (2000) (22)
Neurobehavioural characteristics and relapse in addiction - Reply on Substance use disorders and the orbitofrontal cortex (2006) (21)
Natural course and placebo response in short-term, placebo-controlled studies in major depression: a meta-analysis of published and non-published studies. (2004) (21)
The Relation Between Social Desirability and Different Measures of Heroin Craving (2006) (21)
Risk assessment of gamma-hydroxybutyric acid (GHB) in the Netherlands. (2012) (21)
Impulsivity and attentional bias as predictors of modafinil treatment outcome for retention and drug use in crack-cocaine dependent patients: Results of a randomised controlled trial (2016) (21)
What can the Swiss and Dutch trials tell us about the potential risks associated with heroin prescribing? (2003) (21)
Suicide risk in placebo-controlled trials of treatment for acute manic episode and prevention of manic-depressive episode. (2005) (21)
The effect of clozapine and risperidone on attentional bias in patients with schizophrenia and a cannabis use disorder: An fMRI study (2014) (21)
Process characterisation, optimisation and validation of production of diacetylmorphine/caffeine sachets: a design of experiments approach. (2004) (21)
Cue-induced striatal activity in frequent cannabis users independently predicts cannabis problem severity three years later (2016) (21)
Fear extinction, persistent disruptive behavior and psychopathic traits: fMRI in late adolescence. (2016) (20)
Is deep brain stimulation a treatment option for addiction? (2015) (20)
The effect of Ecstasy on memory is moderated by a functional polymorphism in the cathechol-O-methyltransferase (COMT) gene (2009) (19)
Predictive validity of a culturally informed diagnosis of schizophrenia: A 30month follow-up study with first episode psychosis (2011) (19)
Screening for bipolar disorders in patients with alcohol or substance use disorders: performance of the mood disorder questionnaire. (2011) (19)
Explaining the Differences in Opioid Overdose Deaths between Scotland and England/Wales: Implications for European Opioid Policies (2021) (19)
The Role of Study and Work in Cannabis Use and Dependence Trajectories among Young Adult Frequent Cannabis Users (2013) (19)
Three-Year Course of Cannabis Dependence and Prediction of Persistence (2015) (19)
Impact of a transient instability of the ecstasy market on health concerns and drug use patterns in The Netherlands. (2012) (19)
Relapse and recurrence prevention in major depression: a critical review of placebo-controlled efficacy studies with special emphasis on methodological issues (2001) (19)
The use and helpfulness of self-management strategies for depression: The experiences of patients (2018) (19)
Guidelines for allocating outpatient alcohol abusers to levels of care: Predictive validity. (2011) (18)
The effect of N-acetylcysteine and working memory training on cocaine use, craving and inhibition in regular cocaine users: correspondence of lab assessments and Ecological Momentary Assessment. (2018) (18)
Addiction and Autism: A Remarkable Comorbidity? (2014) (18)
Safety and tolerability of as-needed nalmefene in the treatment of alcohol dependence: results from the Phase III clinical programme (2015) (18)
Effect of early and late compliance on the effectiveness of acamprosate in the treatment of alcohol dependence. (2010) (18)
Adverse effects of GHB-induced coma on long-term memory and related brain function. (2018) (18)
Comparing the effect of clozapine and risperidone on cue reactivity in male patients with schizophrenia and a cannabis use disorder: A randomized fMRI study (2017) (18)
Need for care and life satisfaction in adult substance use disorder patients with and without attention deficit hyperactivity disorder (ADHD) or autism spectrum disorder (ASD). (2015) (18)
How real are patients in placebo-controlled studies of acute manic episode? (2004) (18)
Forum: decriminalization of cannabis (2008) (18)
Craving for cannabis in patients with psychotic disorder, their non‐affected siblings and healthy controls: psychometric analysis of the obsessive compulsive drug use scale (2012) (18)
The Effect of High-Frequency Repetitive Transcranial Magnetic Stimulation on Emotion Processing, Reappraisal, and Craving in Alcohol Use Disorder Patients and Healthy Controls: A Functional Magnetic Resonance Imaging Study (2019) (18)
Genomic relationships across psychiatric disorders including substance use disorders. (2021) (17)
Screening for illicit heroin use in patients in a heroin-assisted treatment program. (2006) (17)
Prefrontal Glx and GABA concentrations and impulsivity in cigarette smokers and smoking polysubstance users. (2017) (17)
Anxiety Disorders: Treatable regardless of the Severity of Comorbid Alcohol Dependence (2007) (17)
Reliability and Discriminant Validity of Dynamic Reoffending Risk Indicators in Forensic Clinical Practice (2005) (17)
Varenicline increases in vivo striatal dopamine D2/3 receptor binding: an ultra-high-resolution pinhole [123I]IBZM SPECT study in rats. (2012) (17)
Variants of opioid system genes are associated with non-dependent opioid use and heroin dependence. (2016) (17)
Factors associated with victimization in dual diagnosis patients. (2018) (17)
Dopamine gene variants in opioid addiction: comparison of dependent patients, nondependent users and healthy controls. (2018) (17)
Diagnosing ADHD during active substance use: Feasible or flawed? (2017) (17)
Differential Effects of Left and Right Prefrontal High-Frequency Repetitive Transcranial Magnetic Stimulation on Resting-State Functional Magnetic Resonance Imaging in Healthy Individuals (2017) (17)
Two new neurophysiological indices of cocaine craving: evoked brain potentials and cue modulated startle reflex (2004) (16)
Risk assessment of GBL as a substitute for the illicit drug GHB in the Netherlands. A comparison of the risks of GBL versus GHB. (2014) (16)
Emotion Processing, Reappraisal, and Craving in Alcohol Dependence: A Functional Magnetic Resonance Imaging Study (2019) (16)
Effect of modafinil on cognitive functions in alcohol dependent patients: A randomized, placebo-controlled trial (2013) (16)
Burden and Expressed Emotion of Caregivers in Cases of Adult Substance Use Disorder with and Without Attention Deficit/Hyperactivity Disorder or Autism Spectrum Disorder (2015) (16)
The role of leisure and delinquency in frequent cannabis use and dependence trajectories among young adults. (2015) (16)
Modafinil in the treatment of crack-cocaine dependence in the Netherlands: Results of an open-label randomised controlled feasibility trial (2015) (16)
N-acetyl cysteine in the treatment of alcohol use disorder in patients with liver disease: Rationale for further research (2018) (16)
Post-GWAS analysis of six substance use traits improves the identification and functional interpretation of genetic risk loci. (2019) (16)
Predictive validity of treatment allocation guidelines on drinking outcome in alcohol-dependent patients. (2013) (16)
Efficacy and Tolerability of Naltrexone in the Treatment of Alcohol Dependence: Oral versus Injectable Delivery (2007) (15)
Risk Factors for Borderline Personality Disorder in Treatment Seeking Patients with a Substance Use Disorder: An International Multicenter Study (2015) (15)
Standardized assessment in substance abuse treatment in the Netherlands: The case of the Addiction Severity Index and new developments (2004) (15)
Ranking the harm of non-medically used prescription opioids in the UK. (2015) (15)
Psychometric Evaluation of the Dutch Version of the Impulsive/Premeditated Aggression Scale (IPAS) in Male and Female Prisoners (2013) (15)
The effect of N-acetylcysteine on brain glutamate and gamma-aminobutyric acid concentrations and on smoking cessation: A randomized, double-blind, placebo-controlled trial (2017) (15)
Mast cell mediator tryptase levels after inhalation or intravenous administration of high doses pharmaceutically prepared heroin. (2006) (15)
Sensitivity of the Addiction Severity Index Physical and Sexual Assault Items: Preliminary Findings on Gender Differences (2001) (14)
Hyperresponsiveness of the Neural Fear Network During Fear Conditioning and Extinction Learning in Male Cocaine Users. (2016) (14)
ECNP consensus meeting March 2003 guidelines for the investigation of efficacy in substance use disorders (2006) (14)
Reactivity to social stress in ethnic minority men (2016) (14)
Dangers involved in rapid opioid detoxification while using opioid antagonists: dehydration and renal failure. (2002) (14)
Cue exposure therapy for opiate dependent clients (2005) (14)
Prevalence and characteristics of opioid-related deaths involving alcohol in Ontario, Canada. (2017) (14)
The impact of second generation antipsychotics on insight in schizophrenia: Results from 14 randomized, placebo controlled trials (2017) (14)
Sex role stereotypes and clinical judgement: how therapists view their alcoholic patients. (1993) (13)
Patient‐treatment matching with anti‐craving medications in alcohol‐dependent patients: A review on phenotypic, endophenotypic and genetic indicators (2005) (13)
Enhanced Amygdala-Striatal Functional Connectivity during the Processing of Cocaine Cues in Male Cocaine Users with a History of Childhood Trauma (2018) (13)
A quality framework for addiction treatment programs. (2005) (13)
Prediction of drop-out and outcome in integrated cognitive behavioral therapy for ADHD and SUD: Results from a randomized clinical trial. (2019) (13)
Analysis of diacetylmorphine, caffeine, and degradation products after volatilization of pharmaceutical heroin for inhalation. (2006) (13)
Patterns of Craving and Pharmacokinetics in Long-Term Opiate Addicts in Methadone Maintenance Therapy (1996) (13)
Acceptability of Extended-Release Naltrexone by Heroin-Dependent Patients and Addiction Treatment Providers in the Netherlands (2016) (13)
Fatal and non-fatal health incidents related to recreational ecstasy use (2020) (13)
Psychotic reactions to daily life stress and dopamine function in people with severe hearing impairment (2014) (13)
Development and Manufacture of Diacetylmorphine/Caffeine Sachets for Inhalation Via ‘Chasing the Dragon’ by Heroin Addicts (2004) (12)
Pharmacokinetic comparison of two methods of heroin smoking: ‘chasing the dragon’ versus the use of a heating device (2005) (12)
Measuring the learning capacity of organisations: development and factor analysis of the Questionnaire for Learning Organizations (2011) (12)
Dimensional models and neurobiology of personality disorders. (1999) (12)
The relationship of quality and price of the psychostimulants cocaine and amphetamine with health care outcomes. (2010) (12)
The high harm score of alcohol. Time for drug policy to be revisited? (2013) (12)
Interrater reliability for Kernberg's structural interview for assessing personality organization. (2009) (12)
Differential Diagnosis in Patients with Substance Use Disorder and/or Attention-Deficit/Hyperactivity Disorder Using Continuous Performance Test (2020) (12)
Dopamine transporter occupancy by methylphenidate and impulsivity in adult ADHD (2014) (12)
Medicinal cannabis (Bedrolite) substitution therapy in inpatients with a psychotic disorder and a comorbid cannabis use disorder: A case series (2018) (12)
The Role of Parents, Peers and Partners in Cannabis Use and Dependence Trajectories among Young Adult Frequent Users (2013) (12)
Personal recovery in individuals diagnosed with substance use disorder (SUD) and co-occurring attention deficit/hyperactivity disorder (ADHD) or autism spectrum disorder (ASD). (2015) (12)
Genomic relationships across psychiatric disorders including substance use disorders (2020) (12)
The high harm score of alcohol. Time for drug policy to be revisited (2013) (11)
Doubt in the Insula: Risk Processing in Obsessive-Compulsive Disorder (2016) (11)
Effect of GHB-use and GHB-induced comas on dorsolateral prefrontal cortex functioning in humans (2018) (11)
Assessment of violence risk in youth for juvenile court: relevant factors for clinical judgment. (2008) (11)
Do candidate genes discriminate patients with an autism spectrum disorder from those with attention deficit/hyperactivity disorder and is there an effect of lifetime substance use disorders? (2010) (11)
Treatment Duration and Premature Termination of Psychotherapy in Personality Disorders: Predictive Performance of Psychodynamic Personality Functioning (2012) (11)
Self-reported cue-induced physical symptoms of craving as an indicator of cocaine dependence. (2015) (11)
Cannabinoid‐1 receptor antagonist rimonabant (SR141716) increases striatal dopamine D2 receptor availability (2013) (11)
Effects of MDMA (ecstasy) use and abstention on serotonin neurons (2002) (11)
Forum: Decriminalization of cannabis. (2008) (11)
Use of the Fagerström test to assess differences in the degree of nicotine dependence in smokers from five ethnic groups: The HELIUS study. (2019) (10)
Temporal stability of diagnostic criteria for antisocial personality disorder in male alcohol dependent patients. (1998) (10)
Craving patterns in methadone maintenance treatment with dextromoramide as adjuvant. (1999) (10)
The suitability of oral diacetylmorphine in treatment-refractory patients with heroin dependence: A scoping review. (2021) (10)
Geographic variation in efficacy of atypical antipsychotics for the acute treatment of schizophrenia – An individual patient data meta-analysis (2014) (10)
Guideline for Screening, Diagnosis and Treatment of ADHD in Adults with Substance Use Disorders (2014) (10)
[Five years of ROM in substance abuse treatment centres in the Netherlands]. (2012) (10)
The International Collaboration on ADHD and Substance Abuse (ICASA): Mission, Results, and Future Activities (2020) (10)
Exploring the role of low-frequency and rare exonic variants in alcohol and tobacco use. (2018) (10)
Predicting Ecstasy Use among Young People at Risk: A Prospective Study of Initially Ecstasy-Naive Subjects (2008) (10)
Personality Disorders and Addiction (1995) (10)
Barriers to Implementation of Treatment Guidelines for ADHD in Adults With Substance Use Disorder (2014) (10)
The relationship between social dysfunctioning and psychopathology (1993) (10)
Ranking of drugs: a more balanced risk-assessment. (2010) (9)
Baseline severity and the prediction of placebo response in clinical trials for alcohol dependence: A meta‐regression analysis to develop an enrichment strategy (2021) (9)
Methamphetamine Use and Antipsychotic-related Extrapyramidal Side-effects in Patients with Psychotic Disorders (2020) (9)
Design of a syndemic based intervention to facilitate care for men who have sex with men with high risk behaviour: the syn.bas.in randomized controlled trial (2017) (9)
Physical and Mental Health and Social Functioning in Older Alcohol-Dependent Inpatients: The Role of Age of Onset (2014) (9)
Monitoring Opioids in Europe: The Need for Shared Definitions and Measuring Drivers of Opioid Use and Related Harms (2022) (9)
Efficacy of cocaine contingency management in heroin-assisted treatment: Results of a randomized controlled trial. (2016) (9)
VMAT2 gene (SLC18A2) variants associated with a greater risk for developing opioid dependence. (2019) (9)
Volatilisation of diacetylmorphine: in vitro simulation of 'chasing the dragon'. (2006) (8)
Cognitive functioning associated with stimulant use in patients with non-affective psychosis, their unaffected siblings and healthy controls (2013) (8)
Efficacy of drug treatment for acute mania differs across geographic regions: An individual patient data meta-analysis of placebo-controlled studies (2015) (8)
Effects of Recreational GHB Use and Multiple GHB-Induced Comas on Brain Structure and Impulsivity (2020) (8)
Treating alcohol dependence with an abuse and misuse deterrent formulation of sodium oxybate: Results of a randomised, double-blind, placebo-controlled study (2021) (8)
How credible are international databases for understanding substance use and related problems? (2015) (8)
Editorial: Craving and Relapse Prevention (1997) (8)
The effect of N-acetylcysteine and working memory training on neural mechanisms of working memory and cue reactivity in regular cocaine users (2019) (8)
Diagnosis and treatment of patients with comorbid substance use disorder and adult attention-deficit and hyperactivity disorder: a review of recent publications. (2019) (8)
Harm related to recreational ketamine use and its relevance for the clinical use of ketamine. A systematic review and comparison study. (2021) (8)
Recreational use of GHB is associated with alterations of resting state functional connectivity of the central executive and default mode networks (2019) (8)
Early developmental, temperamental and educational problems in ‘substance use disorder’ patients with and without ADHD. Does ADHD make a difference? (2015) (8)
Ranking of drugs: a more balanced risk-assessment (2010) (7)
Alcohol- and drug-related public violence in Europe (2019) (7)
Clinical effects beyond cocaine use of sustained-release dexamphetamine for the treatment of cocaine dependent patients with comorbid opioid dependence: secondary analysis of a double-blind, placebo-controlled randomized trial. (2019) (7)
Deuterodiacetylmorphine as a marker for use of illicit heroin by addicts in a heroin-assisted treatment program. (2005) (7)
Social factors and readmission after inpatient detoxification in older alcohol-dependent patients. (2015) (7)
Self‐wise, Other‐wise, Streetwise (SOS) training, an intervention to prevent victimization in dual‐diagnosis patients: results from a randomized clinical trial (2018) (7)
Reprint of The effect of N-acetylcysteine and working memory training on cocaine use, craving and inhibition in regular cocaine users: correspondence of lab assessments and Ecological Momentary Assessment. (2018) (7)
Effect of alcohol use on the course of bipolar disorder: one‐year follow‐up study using the daily prospective Life Chart method (2014) (7)
Attention Deficit/Hyperactivity Disorder and Global Severity Profiles in Treatment-Seeking Patients with Substance Use Disorders (2020) (7)
The addiction severity index as a first-generation instrument: commentary on ‘studies of the reliability and validity of the ASI’ by K. Mäkelä (2004) (7)
Adverse events in clinical treatments with serotonergic psychedelics and MDMA: A mixed-methods systematic review (2022) (7)
Family history of alcohol dependence modulates functional neurophysiology in mood/anxiety disorders (2012) (7)
Influence of Gamma-Hydroxybutyric Acid-Use and Gamma-Hydroxybutyric Acid-Induced Coma on Affect and the Affective Network (2019) (7)
Progress in Mind: Focus on Alcohol Use Disorders, an Elsevier Resource Centre (2015) (6)
Recreational N2 O use: just laughing or really bad news? (2021) (6)
Association of variants of prodynorphin promoter 68-bp repeats in caucasians with opioid dependence diagnosis: Effect on age trajectory of heroin use (2019) (6)
Attention Deficit Hyperactivity Disorder Increases Nicotine Addiction Severity in Adults Seeking Treatment for Substance Use Disorders: The Role of Personality Disorders (2020) (6)
[Dutch research on the effectiveness of medical prescription of heroin; background, research design and preliminary results]. (2000) (6)
Substance use disorders, trauma, and PTSD (2015) (6)
Does Insight Affect the Efficacy of Antipsychotics in Acute Mania?: An Individual Patient Data Regression Meta-Analysis (2016) (6)
Trauma, trauma-related distress, and perceived parental dysfunction: associations with severity of drinking problems in treated alcoholics. (2002) (6)
Treatment outcome of alcohol use disorder outpatients with or without medically assisted detoxification. (2014) (6)
Pharmaceutical development of an intravenous dosage form of diacetylmorphine hydrochloride. (2004) (6)
The structural coherence of clinically derived dynamic indicators of reoffending risk. (2004) (6)
Comorbidity of personality disorders and substance use disorders (2004) (6)
Placebo response in antipsychotic trials of patients with acute mania Results of an individual patient data meta-analysis (2015) (6)
The therapeutic potential of psilocybin: a systematic review (2022) (6)
A guide on gene prioritization in studies of psychiatric disorders (2015) (6)
Near-fatal persistent anion- and osmolal-gap acidosis due to massive gamma-butyrolactone/ethanol intoxication (2015) (6)
Aversive Counterconditioning Attenuates Reward Signaling in the Ventral Striatum (2016) (6)
Enhancing help-seeking behaviour among men who have sex with men at risk for sexually transmitted infections: the syn.bas.in randomised controlled trial (2020) (5)
PMH17 COST-UTILITY ANALYSIS OF MEDICAL CO-PRESCRIPTION OF HEROIN COMPARED WITH METHADONE MAINTENANCE TREATMENT FOR CHRONIC, TREATMENT RESISTANT HEROIN ADDICTS (2004) (5)
1105 – Long-term Efficacy Of Nalmefene As-needed In Alcohol Dependent Patients With High Drinking Risk Levels: Results Of a Subgroup Analysis (2013) (5)
Validity of the ADHD module of the Mini International Neuropsychiatric Interview PLUS for screening of adult ADHD in treatment seeking substance use disorder patients: ADHD screening with MINI-Plus. (2020) (5)
Experiences with a checklist for DSM‐III‐R in the Russian Federation and Belarus. A study about the interrater reliability and the concurrent validity of the Munich Diagnostic Checklist for DSM‐III‐R (1995) (5)
Influence of Treatment with Inhalable Heroin on Pulmonary Function (2011) (5)
Acceptance of pharmaceutical cannabis substitution by cannabis using patients with schizophrenia (2018) (5)
[The effectiveness of anxiety treatment on alcohol-dependent patients with a comorbid phobic disorder: a randomised controlled trial]. (2008) (5)
Speaking fluently with baclofen? (2017) (5)
Treatment of Adolescents with Concurrent Substance Use Disorder and Attention-Deficit/Hyperactivity Disorder: A Systematic Review (2021) (5)
Correction: The use and helpfulness of self-management strategies for depression: The experiences of patients (2018) (5)
Treatment-Disrupting Behaviors during Psychotherapy of Patients With Personality Disorders: The Predictive Power of Psychodynamic Personality Diagnosis (2011) (5)
Baclofen: A Game Changer in the Treatment of Alcohol Dependence. (2019) (5)
Gambling Disorder and Substance-Related Disorders: Similarities and Differences (2019) (5)
Substance use disorders and the orbitofrontal cortex (vol 187, pg 209, 2002) (2005) (5)
A Comparison of Excessive Drinking, Binge Drinking and Alcohol Dependence in Ethnic Minority Groups in the Netherlands: The HELIUS Study (2019) (5)
Early Nonresponse in the Antipsychotic Treatment of Acute Mania: A Criterion for Reconsidering Treatment? Results From an Individual Patient Data Meta-Analysis. (2016) (5)
Converging evidence for specific neurotoxic effects of ecstasy on the thalamus (2007) (5)
Alcohol use disorders and the course of depressive and anxiety (2012) (4)
Memories of Parental Rearing and Personality Pathology in Male Alcoholics (1995) (4)
State of the art: neurocognitieve effecten van verslaving (2012) (4)
Withdrawal of attention rather than pharmacological treatment affects suicide rates in depressed children and adolescents. (2007) (4)
A quality framework for addiction treatment programmes: Results of a concept mapping strategy (2005) (4)
Effects of Methylphenidate During Fear Learning in Antisocial Adolescents: A Randomized Controlled fMRI Trial. (2018) (4)
controlled trials resistant heroin addicts: two randomised Medical prescription of heroin to treatment (2005) (4)
Nitrous oxide–induced reproductive risks: Should recreational nitrous oxide users worry? (2022) (4)
Increasing recreational nitrous oxide use: Should we worry? A narrative review (2022) (4)
Often Overlooked and Ignored, but Do Not Underestimate Its Relevance: ADHD in Addiction – Addiction in ADHD (2020) (4)
Incidence of schizophrenia among Moroccan immigrants to the Netherlands. Response to letter written by Selten et al. (2011) (4)
1107 – Esense 1 - Randomised Controlled 6-month Study Of As-needed Nalmefene: Subgroup Analysis Of Alcohol Dependent Patients With High Drinking Risk Level (2013) (4)
FS09.1 Diacetylmorphine (heroin) allergy (2004) (4)
Epidemiology of cocaine and crack: Implications for drug policy and treatment planning (2005) (4)
[Summary of the practice guideline for the diagnosis and treatment of ADHD in adolescents and adults with addictions]. (2013) (4)
Child sexual abuse and substance use disorders: role of psychiatric comorbidity (2004) (4)
Subchronic administration of short-acting naltrexone has no effect on striatal dopamine transporter availability, food intake or body weight gain in rats (2015) (4)
High-potency cannabis and incident psychosis: correcting the causal assumption. (2019) (3)
Causal pathways between personality pathology and substance use disorders (2005) (3)
A randomised controlled trial of outpatient versus inpatient integrated treatment of dual diagnosis patients: a failed but informative study (2012) (3)
Onset and Severity of Early Disruptive Behavioral Disorders in Treatment-Seeking Substance Use Disorder Patients with and without Attention-Deficit/Hyperactivity Disorder (2020) (3)
The Discriminant Validity of Alcohol Use Disorder in Well-Functioning Men with Hazardous Alcohol Use (2003) (3)
Engagement of pleasant activities in patients with substance use disorders: a correlational study. (2014) (3)
Hard Boiled: Alcohol Use as a Risk Factor for MDMA-Induced Hyperthermia: a Systematic Review (2021) (3)
T264. Differential Effects of Left and Right Prefrontal High Frequency rTMS on Resting State fMRI in Healthy Individuals (2018) (3)
Obesity an Addiction? Imaging of Neurotransmitter Systems in Obesity (2014) (3)
Short-term efficacy of tricyclic antidepressants revisited: a meta-analytic study (vol 11, pg 173, 2001) (2001) (3)
Effect of Methylphenidate on Resting-State Connectivity in Adolescents With a Disruptive Behavior Disorder: A Double-Blind Randomized Placebo-Controlled fMRI Study (2021) (3)
Functional MR Imaging on an Open 1T MR Imaging System: Exploiting the Advantages of an Open MR Imaging System for Functional MR Imaging (2011) (3)
What lessons from Europe’s experience could be applied in the United States in response to the opioid addiction and overdose crisis? (2022) (3)
Effect of early dysphoric response and cannabis use on discontinuation of olanzapine or risperidone in patients with early psychosis. (2010) (3)
Wim van den Brink and colleagues reply to Des Spence and Alain Braillon (2014) (3)
[Adolescence, schizophrenia and drug abuse: interactive vulnerability. A hypothesis]. (2007) (3)
Incidence of tuberculosis among drug addicts in Amsterdam methadone programmes (1995) (3)
[Detoxication in opiate addiction and prevention of recurrence: administration of naltrexone and cognitive behavior therapy]. (1997) (3)
Contribution of Alcohol and Nicotine Dependence to the Prevalence of Depressed Mood in Different Ethnic Groups in The Netherlands: The HELIUS Study (2020) (3)
Association of Serotonin Transporter (SERT) Polymorphisms with Opioid Dependence and Dimensional Aspects of Cocaine Use in a Caucasian Cohort of Opioid Users (2021) (3)
Deep brain stimulation and addiction (2014) (3)
Cognitive Impairment Following Clinical or Recreational Use of Gammahydroxybutyric Acid (GHB): A Systematic Review (2021) (3)
Heroin assisted treatment (2009) (3)
Beneficial effect of heroin in heroin addicts (2002) (3)
Developing a new national MDMA policy: Results of a multi-decision multi-criterion decision analysis (2021) (2)
Smoking and the risk for bipolar disorder: causal evidence from a bidirectional Mendelian randomization study (2019) (2)
Further evidence for association of GAL, GALR1 and NPY1R variants with opioid dependence. (2020) (2)
Mechanisms Involved in the Neurotoxicity and Abuse Liability of Nitrous Oxide: A Narrative Review (2022) (2)
Does self-medication predict the persistence or rather the recurrence of alcohol dependence? (2014) (2)
Use characteristics and harm potential of ecstasy in The Netherlands (2020) (2)
P-59 - Shifting the Paradigm: Reduction of Alcohol Consumption in Alcohol Dependent Patients - a Randomised, Double-blind, Placebo-controlled Study of Nalmefene, As-needed Use (2012) (2)
WHO Study on the reliability and validity of the alcohol and drug use disorder instruments: Overview of methods and results (vol 47, pg 161, 1997) (1998) (2)
Prescription of heroin to treatment resistant heroin addicts (2004) (2)
Association Tests of Striatal DAT Availability and SNPs That Impact a Novel Splice Variant in the DAT Gene (2012) (2)
European Addiction Research Becomes the Official Journal of the European Federation of Addiction Societies (2016) (2)
Contributions from Neuroscience and Neuropsychology (2013) (2)
Obsessive Compulsive Drug Use Scale (2013) (2)
A randomised Methadone-controlled heroin trial in opiod-addicts (2002) (2)
Consequences of the Chernobyl disaster. Illness or illness behaviour (1999) (2)
The role of psychosocial interventions in the pharmacological treatment of alcohol dependence (2003) (2)
Gender and the relationship between childhood trauma dissociation and alcohol dependence (2005) (2)
The effect of N-acetylcysteine and working memory training on glutamate concentrations in the dACC and rACC in regular cocaine users – A randomized proof of concept study (2021) (2)
Posttraumatic stress disorder with secondary psychotic features (2013) (2)
[Addictive behaviours from DSM-IV to DSM-5]. (2014) (2)
Suicide risk in placebo-controlled trials for major depression (2001) (2)
The clinical course of comorbid substance use disorder and attention deficit/hyperactivity disorder: protocol and clinical characteristics of the INCAS study (2022) (2)
No evidence of decrease in cognitive function in users of low-dose ecstasy - Reply (2008) (2)
Opiate Craving and the Presence of Psychopathology (1997) (2)
Relating Compulsivity and Impulsivity With Severity of Behavioral Addictions: A Dynamic Interpretation of Large-Scale Cross-Sectional Findings (2022) (2)
Net gain analysis, an addition to responder analysis--The case of antipsychotic treatment of acute mania. (2015) (2)
Response to “Baclofen and alcohol use disorders: From miracle to mirage” (2017) (1)
S.10.04 Neurocognitive deficits in pathological gambling and related disorders (2006) (1)
Treatment options for heroin and cocaine addiction (2003) (1)
1108 – Esense 2 - Randomised Controlled 6-month Study Of As-needed Nalmefene: Subgroup Analysis Of Alcohol Dependent Patients With High Drinking Risk Level (2013) (1)
Substance use disorders, trauma, and PTSD (2015) (1)
Addiction and severe psychopathology: a randomized controlled study comparing the efficacy of inpatient and outpatient integrated treatment of dual diagnosis patients (2003) (1)
Sodium oxybate for the maintenance of abstinence in alcohol-dependent patients: An international, multicenter, randomized, double-blind, placebo-controlled trial (2022) (1)
P.1.j.031 The efficacy of N-acetylcysteine on smoking cessation, impulsivity and cue reactivity in heavy smokers (2015) (1)
Outcome of anxiety and depression in general health care: a three-wave 3.5-year study of psychopathology, disability and life stress (1994) (1)
Gene variants of the opioid system – Relationship to heroin self-exposure, addiction, and treatment (2015) (1)
Demographic and Clinical Characteristics of Regular GHB-Users with and without GHB-Induced Comas (2020) (1)
Alcohol use disorder (2020) (1)
Neurotoxicity due to Repeated Comas Following Excessive Use of Gamma-Hydroxybutyric Acid (2016) (1)
A comparative study of the harms of nitrous oxide and poppers using the MCDA approach (2022) (1)
trialstreatment in heroin addicts in two randomised compared with methadone maintenance Cost utility analysis of co-prescribed heroin (2005) (1)
Smoking As an Outcome Moderator In the Treatment of Alcohol Use Disorders (2022) (1)
Slamsex in The Netherlands among men who have sex with men (MSM): use patterns, motives, and adverse effects. (2022) (1)
Treatment of drug-addicted detainees (2003) (1)
The Added Value of Pharmacotherapy to Cognitive Behavior Therapy And Vice Versa in the Treatment of Alcohol Use Disorders: A Systematic Review (2022) (1)
[Steep increase in prescribed opioids in the Netherlands. Are we going the same way as the U.S.?]. (2015) (1)
P.6.e.001 Cognitive flexibility in pathological gambling and alcohol dependence: an fMRI study (2010) (1)
New: The European Addiction Research Award (2018) (1)
SOCIAL EXCLUSION AND SENSITIZATION OF THE DOPAMINE SYSTEM: A [123I]IBZM-SPECT STUDY IN YOUNG ADULTS WITH SERIOUS HEARING IMPAIRMENT (2014) (1)
Neurobiological Information and Consideration in Dutch Pre-trial Forensic Reports of Juvenile Criminal Offenders (2019) (1)
Differentiating Treatment-Seeking Substance-Use Disordered Patients: Support for a Staging Model (2017) (1)
Opioid receptors and addiction: a genetic approach (2003) (1)
P.6.b.004 Efficacy of nalmefene as-needed in alcohol dependent patients with high drinking risk level: subgroup analysis of two studies (2013) (1)
DSM-IV, ICD-10 en het Craving Withdrawal Model voor alcoholisme (2004) (1)
Alcohol use and domestic aggression (1998) (1)
Validity of the one-criterion threshold for an alcohol abuse diagnosis. (2005) (1)
EPA-0405 – Tolerability and Safety of As-needed Nalmefene in the Treatment of Alcohol Dependence: Results from the Phase 3 Programme (2014) (1)
The relationship between impulsivity and craving in alcohol dependent patients (2012) (1)
Progressive Alcohol Dependence and Habits in the Human Brain (2014) (1)
Defining Compulsive Behavior (2019) (1)
Network Analysis of DSM Symptoms of Substance Use Disorders and Frequently Co-Occurring Mental Disorders in Patients with Substance Use Disorder Who Seek Treatment (2022) (1)
Netherlands personality disorder : 12-month , randomised clinical trial in The Dialectical behaviour therapy for women with borderline (2003) (1)
Poster #T245 COGNITIVE FUNCTIONING ASSOCIATED WITH STIMULANT USE IN PATIENTS WITH NON-AFFECTIVE PSYCHOSIS, THEIR UNAFFECTED SIBLINGS AND HEALTHY CONTROLS (2014) (1)
Self-Medication of ADHD Symptoms: Does Caffeine Have a Role? (2022) (1)
[Recreative ecstasy use in the Netherlands: use characteristics, health risks and criminality]. (2020) (1)
Effect of extended-release naltrexone on striatal dopamine transporter availability, depression and anhedonia in heroin-dependent patients (2015) (1)
[Personalised treatment of disorders in the use of alcohol and nicotine]. (2018) (1)
Consensus International sur le dépistage, le diagnostic et le traitement des patients avec troubles de l’usage de substances en cas de comorbidité avec un trouble du déficit de l’attention avec ou sans hyperactivité (2022) (1)
Neurobehavioural characteristics and relapse in addiction: author's reply (2006) (1)
Pharmacokinetics of Sustained-Release Oral Dexamphetamine Sulfate in Cocaine and Heroin-Dependent Patients (2018) (1)
P5.000 Haloperidol reduces excessive attention onheroin cues in abstinent heroin dependent patients (2004) (1)
Suicide risk in placebo-controlled studies. Authors' reply (2002) (1)
Consequences of the use of different classification systems: a comparison of the DSM‐III‐R and the ICD‐10 for depression (1999) (1)
P.6.b.005 Long-term efficacy of nalmefene as-needed in alcohol dependent patients with high drinking risk level: results of a subgroup analysis (2013) (0)
UvA-DARE Cue-induced striatal activity in frequent cannabis users independently predicts cannabis problem severity three years later (2016) (0)
61 THE MEDIATING ROLE OF SOCIOECONOMIC STATUS AND EDUCATIONAL ATTAINMENT IN THE HERITABILITY OF AND GENETIC ASSOCIATION BETWEEN A RANGE OF SUBSTANCE USE TRAITS AND PSYCHIATRIC DISORDERS (2019) (0)
JS01-03 - Improved anti-addiction therapeutic programmes based on pharmacogenetic criteria (2011) (0)
C.12.01 The need for expanding the treatment continuum in the treatment of alcohol dependence (2012) (0)
Deep Brain Stimulation Normalizes Frontostriatal Connectivity in Obsessive-Compulsive Disorder (2013) (0)
S.10.03 Psychological strategies for relapse prevention in alcoholism (1997) (0)
P.2.034 Wrong expectations? Expectancy coding of gains and losses in alcohol dependent subjects and pathological gamblers (2010) (0)
Gene variants of the dopaminergic system are associated with non-dependent heroin use and heroin dependence (2017) (0)
Smoking and the risk for bipolar disorder: causal evidence from a bidirectional Mendelian randomisation study (2020) (0)
First prospective study on the effects of low doses ecstasy on the brain in new ecstasy users, using a combination of advanced MR imaging techniques and [I-123]beta-CIT SPECT (2007) (0)
S.07.03 Effects of varenicline on dopamine D2/3 receptor binding in rats using ex vivo phosphor storage imaging (2009) (0)
Poster #T82 SOCIAL STRESS AND PSYCHOTIC SYMPTOMS IN THE DAILY LIFE OF YOUNG ADULTS WITH HEARING IMPAIRMENT (2014) (0)
[Developments in pharmacotherapy: personalised pharmacotherapy?]. (2013) (0)
UvA-DARE ( Digital Academic Repository ) Neurobiological aspects of obesity : dopamine , serotonin , and imaging (2012) (0)
The role pharmacokinetics and psychopathology in the prediction of craving among opiate addicts in methadone maintenance therapy (1996) (0)
Physicians application of brief interventions for patients with excessive alcohol consumption and smoking habits in a general hospital (2003) (0)
S.15.03 Hyperresponsiveness of the neural fear network in cocaine abuse disorder (2015) (0)
O6FREE ORAL COMMUNICATIONS 6: PSYCHOSOCIAL FACTORS AND ALCOHOL USE DISORDERSO6.1SEXUAL ORIENTATION AND DRUG OF CHOICEO6.2SUSCEPTIBILITY OF AGE AND GENDER TO INTERMITTENT ALCOHOL ABUSEO6.3HIGH EDUCATIONAL LEVELS AS PROTECTIVE FACTOR AGAINST DRUG AND ALCOHOL CONSUMPTIONO6.4AGE OF ONSET, PHYSICAL AND M (2013) (0)
Predictors of acamprosate efficacy in the treatment of alcohol dependence: results from a pooled analysis of 7 European trials (2004) (0)
P.4.009 The effect of cue reactivity on striatal reward anticipation in alcohol dependent individuals (2017) (0)
Evaluation of the Penal Care Facility for Drug Addicts (SOV project) (2002) (0)
UvA-DARE (Digital Academic Repository) A transdiagnostic dimensional approach towards a neuropsychological assessment for addiction an international Delphi consensus study (2019) (0)
Amsterdam Motives for Drinking Scale (2019) (0)
disordersuse disorders and the course of depressive and anxiety (2013) (0)
C.07.02 Treatment options for alcohol dependence (2013) (0)
Department of Error (2021) (0)
Blinding in clozapine trials: a problem and a potential solution (2009) (0)
Harm related to recreational ketamine use and its relevance for the clinical use of ketamine. A systematic review and comparison study. (2021) (0)
Authors' reply (2006) (0)
INFLUENCE OF THERAPEUTIC WORKING ALLIANCE ON TREATMENT OUTCOME IN ALCOHOL USE DISORDERED PATIENTS: A PILOT STUDY HIGH LEVELOF BZDS IN PATIENTS AFTER ALCOHOL WITHDRAWALTREATMENT - AN INCOMPLETE DETOXIFICATION? AMONG (2013) (0)
What makes you a real addict? : differences between clinically referred pathological gamblers and alcohol dependents, and non-clinically referred pathological gamblers and alcohol dependents (2010) (0)
European Addiction Research: A New Editor, a New Advisory Board and Intriguing Perspectives (2011) (0)
Prevention of Alcohol Addiction (2015) (0)
Front & Back Matter (2012) (0)
Chemical dissociation in traumatised alcohol-dependent patients: a neurobehavioral study using neurocognitive, neuroimaging and physiological data (2004) (0)
S29.01 - The role of impulsivity in the pathogenesis and treatment of addiction (2008) (0)
P.3.005 N-Acetylcysteine changes glutamate levels in cocaine dependent subjects: an open label [1H] MRS study (2011) (0)
C.11.01 The natural history of alcohol dependence. Genes, endophenotypes, neurobiology, and course of the disease (2015) (0)
P.1.013 The cannabinoid-1 receptor antagonist rimonabant increases striatal dopamine D2/3 receptor availability in rats (2011) (0)
ORIGINAL RESEARCH Functional MR Imaging on an Open 1T MR Imaging System: Exploiting the Advantages of an Open MR Imaging System for Functional MR Imaging (2011) (0)
The neurobiology, psychophysiology and clinical characteristics of distinct pathways to craving in alcoholics (2000) (0)
S.07.06 Specific effects of ecstasy on memory: a new approach to investigate neurotoxic effects in poly-substance ecstasy users (2006) (0)
Evaluation of the Forensic Addiction Clinic (FVK) (2002) (0)
Psychological factors in the relapse of alcohol-addicted patients with an anxiety disorder (1997) (0)
Decision making in pathological gambling: Cardiac and electrodermal concomitants of deficiënt performance (2004) (0)
P.4.b.003 Doubt in the insula: risk processing in obsessive–compulsive disorder (2014) (0)
Essential Evidence-Based Psychopharmacology: Evidence-based pharmacotherapy of illicit substance use disorders (2012) (0)
Authors' reply (2012) (0)
The role of impulsivity, response inhibition and delay discounting in addictive behaviors (2007) (0)
Neuroscience of Pathological Gambling (2012) (0)
Compliance Effect in alcoholism (2006) (0)
C.10.03 Clinical evidence with opioid modulators in alcohol dependence (2014) (0)
Erratum to “Short-term efficacy of tricyclic antidepressants revisited: a meta-analytic study” [Eur. Neuropsychopharmacol. 11 (2001) 173–180] (2001) (0)
P.6.a.004 The effect of naltrexone and acamprosate on cue-induced craving and fysiological cue-reactivity in alcoholics (2007) (0)
The North American opioid crisis: a European perspective (2022) (0)
Reactivity to Daily Life and Experimental Social Stress in Second-Generation Moroccan-Dutch Men (2015) (0)
P.6.e.006 Cue reactivity in pathological gamblers and smokers: an fMRI study of behavioural and substance related addictions (2010) (0)
P.6.e.004 Pathological gambling: is the addictive in the anticipation? An fMRI study (2011) (0)
Dissertations 2003 - MH (2003) (0)
P.3.017 Differential effects of left and right prefrontal magnetic stimulation on resting state connectivity in healthy individuals (2018) (0)
Cannabis policy in The Netherlands: Rationale and design of an experiment with a controlled legal ('closed') cannabis supply chain. (2022) (0)
Misinterpretation in Krsch et al's article. Response to Kirsch et al. Initial severity and antidepressant benefits: a meta-analysisof data submitted to the FDA (2008) (0)
Deep brain stimulation restores frontostriatal network activity in obsessive-compulsive disorder (vol 16, pg 386, 2013) (2014) (0)
Holding on or letting go? Patient experiences of control, context, and care in oral esketamine treatment for treatment-resistant depression: A qualitative study (2022) (0)
S.14.04 Testing the effect of modafinil on functional connectivity and impulsivity in alcohol dependent patients (2013) (0)
Determinants of customer satisfaction with addiction care (1996) (0)
Response Inhibition in Alcohol Dependent Patients : An FMRI Comparison with Depressed/Anxious Patients and Healthy Controls (2013) (0)
The influence of GHB-use and GHB-induced coma on affect and the affective network (2018) (0)
Decade Lecture #1: Current and Future Management of Opioid Dependence (2009) (0)
Science-based practice for methadone treatment: another step forward (2003) (0)
Ethnic differences in response to atypical antipsychotics in patients with schizophrenia: individual patient data meta-analysis of randomised placebo-controlled registration trials submitted to the Dutch Medicines Evaluation Board (2023) (0)
The role of impulsivity, response inhibition and delay discounting in addictive behaviors (2007) (0)
Die 'Richtlinien für die Risiko-Reduzierung beim Cannabiskonsum (RRRCK)': EMPFEHLUNGEN[The 'Lower-Risk Cannabis Use Guidelines (LRCUG)': RECOMMENDATIONS (GERMAN)]. (2023) (0)
Addendum: Deep brain stimulation restores frontostriatal network activity in obsessive-compulsive disorder (2014) (0)
Short-term efﬁcacy of tricyclic antidepressants revisited: a meta-analytic study (2001) (0)
[Combination of anxiety disorder and alcohol dependence]. (1998) (0)
Netherlandsdisorder : 12-month, randomised clinical trial in The Dialectical behaviour therapy for women with borderline (2013) (0)
P-44 - the Role of Impulsivity and Cognitive Functioning in Addiction: a Randomized, Double-blind, Placebo-controlled Trial of Modafinil for Alcohol Dependence (2012) (0)
THE SDSS SCALE—A REPLY TO GONZÁLEZ‐SAIZ (2007) (0)
Tackling rising numbers of opioid prescriptions users. (2020) (0)
Everyday life consequences of illness of substance use disorder (SUD) with co-occurring attention deficit/hyperactivity disorder (ADHD) or autism spectrum disorder (ASD) in adults (2016) (0)
Effects of psychotrophic substances on human cognitive functioning and neuroimaging techniques (2002) (0)
trialsin heroin addicts in two randomised compared with methadone maintenance Cost utility analysis of co-prescribed heroin (2006) (0)
Response inhibition in alcohol dependent patients and patients with depression / anxiety : an fMRI study (2013) (0)
[International Consensus Statement for the Screening, Diagnosis, and Treatment of Adolescents with Concurrent Attention-Deficit/Hyperactivity Disorder and Substance Use Disorder]. (2021) (0)
CS01-01 - Pathological gambling: impulse controle disorder or addiction? (2011) (0)
[Recreative ecstasy use in the Netherlands: use characteristics, health risks and criminality]. (2020) (0)
The Role Pharmacokinetics and Psychopathology in the Prediction of Craving among Opiate Addicts in Methadone Maintenance Therapy (1996) (0)
Low-risk cannabis use is an oxymoron-fischer et al. Respond. (2017) (0)
Different aspects of impulsivity in patients with a borderline personality disorder , patients with a substance use disorder and patients with the combination of both disorders Running title : Impulsivity in BPD and (2016) (0)
O-55 - Characteristics of Substance use Disorders in Adults With Autism or Adhd (2012) (0)
Gender differences in the response to antipsychotic medication in patients with schizophrenia: An individual patient data meta-analysis of placebo-controlled studies (2022) (0)
Science-based practice for methadone treatment: another step forward. (2003) (0)
['Pharmacologic interventions in drug addiction': an advisory report from the Health Council of the Netherlands]. (2003) (0)
Consensus international sur le dépistage, le diagnostic et le traitement des adolescents avec un trouble du déficit de l’attention avec ou sans hyperactivité en cas de comorbidité avec des troubles de l’usage de substances (2022) (0)
Single or low dose of ecstasy, is it safe? A prospective study on neurotoxicity of ecstasy in new ecstasy users (2006) (0)
Department of Error (2019) (0)
Anabolic Androgenic Steroid Use Patterns and Steroid Use Disorders in a Sample of Male Gym Visitors. (2023) (0)
41 EXPLORING THE ROLE OF GENETIC REGULATION OF GENE EXPRESSION IN SUBSTANCE USE AND DEPENDENCE (2019) (0)
The role of impulsivity in the pathogenesis and treatment of addiction (2008) (0)
NDT_A_286536 659..670 (2021) (0)
S.25.04 Matching treatment to patients in heroin assisted treatment of methadone resistant heroin dependent patients: Results of two randomised controlled trials (2004) (0)
Identification of Latent Alcohol Use Groups and Transitions over Time Using a 9-Year Follow-Up Study in the Adult General Population (2022) (0)
Evaluation of implementation of evidence based treatment methods in Dutch addiction treatment centres (2002) (0)
Neurobiology of ADHD and comorbid substance use disorders (2018) (0)
Addiction in anxiety and depression: a 10 year prospective study of co-morbidity, communality of risk factors, public health consequences and barriers to effective care (2003) (0)
Cannabis dependence: predictors, course and treatment seeking (2008) (0)
Desires for Drug Questionnaire (2013) (0)
The effect of alcohol use on smoking cessation: A systematic review. (2023) (0)
Neurostimulation in alcohol dependence: The effect of repetitive transcranial magnetic stimulation on brain function and craving (2016) (0)
Psychobiological Aspects of Cocaine Dependence (2020) (0)
Childhood Trauma and Psychiatric CoMorbidity in Adult Male Alcoholics : Empirical Findings and Clinial Implications (0)
Marijuana Motives Measure--Dutch Extended Version (2015) (0)
P.7.b.009 Distinct resting state functional connectivity correlates for specific dimensions of adolescent psychopathy (2013) (0)
P.1.h.005 Incidence rate and prevalence of obsessive-compulsive disorder in treatment-seeking primary care patients (2009) (0)
S.22.03 Neuroimaging of fear conditioning and reward/punishment anticipation in the persistence of antisocial behaviour (2013) (0)
[Addiction research in the Low Countries: alive and kicking!]. (2013) (0)
EDOCRA - Effectiveness of two methods of detoxification combined with the administration of an opoidantagenist and a biopsychosocial rehabilitation based on the Community Reinforcement Approch (2002) (0)
Specific effects of ecstasy on memory: a new approach to investigate neurotoxic effects in poly-substance ecstasy users (2006) (0)
Las 'Guías para el Uso de Cannabis de Menor Riesgo (GUCMR)': RECOMENDACIONES [The 'Lower-Risk Cannabis Use Guidelines (LRCUG)': RECOMMENDATIONS (SPANISH)]. (2023) (0)
S03-03 Treatment innovations of opiate dependence treatment (2009) (0)
Cue-exposure for alcohol-dependent patients: generalisation of the extinction of craving (2003) (0)
Essential Evidence-Based Psychopharmacology: Evidence-based pharmacotherapy of nicotine and alcohol dependence (2012) (0)
Development of an intake instrument assessing patient characteristics in substance abuse treatment (2004) (0)
Validity of the One-Criterion Threshold for an Alcohol Abuse Diagnosis (2005) (0)
Treatment Innovations of Opiate Dependence Treatment (2009) (0)
Are there different sorts of alcoholics (2004) (0)
SU138SHARING OF GENETIC RISK FACTORS BETWEEN DIFFERENT PROXY MEASURES OF ALCOHOL USE DISORDERS AND RISK OF MENTAL HEALTH DISORDERS (2019) (0)
Cannabis use and lack of medication compliance as risk factors of poor outcome in patients with first episode psychoses: a long-term prospective study (2003) (0)
P.7.a.001 Incentive processing in persistent disruptive behaviour and psychopathic traits: preliminary results of an fMRI study in adolescents (2014) (0)
P.6.d.005 Differential effects of short- and long-term cocaine use on cortical volume, thickness and surface area (2013) (0)
S.17.04 New targets for deep brain stimulation in addiction (2013) (0)
P01.062 Probability maps of glioblastoma indicate variation in surgical decisions between twelve surgical teams (2018) (0)
Poster #252 EFFECT OF CANNABIS USE ON THE COURSE OF SCHIZOPHRENIA IN MALE PATIENTS: A PROSPECTIVE COHORT STUDY (2012) (0)
Developing a new national MDMA policy: Results of a multi-decision multi-criterion decision analysis (MD-MCDA) (2020) (0)
The effect of N-acetylcysteine on brain glutamate and gamma-aminobutyric acid concentrations and on smoking cessation (2017) (0)
P.6.e.004 Glutamate and GABA alterations in the dorsal anterior cingulate cortex in nicotine dependence (2013) (0)
Heroin assisted treatment. (2009) (0)
CS01-01 - Pathological gambling: impulse controle disorder or addiction? (2011) (0)
Linking the pharmacological content of ecstasy tablets to the subjective experiences of drug users (2011) (0)
Neurotoxicity due to repeated comas following excessive use of GHB (2016) (0)
UvA-DARE (Digital Academic Repository) Behavioral and neuroimaging evidence for overreliance on habit learning in alcohol-dependent patients (2013) (0)
P.6.b.007 An fMRI study on the effect of cue reactivity on striatal reward anticipation in alcohol dependent patients (2017) (0)
Prevention of Alcohol Addiction (2015) (0)
Psychological factors in the epidemiology of toxic disasters: Lessons from Chernobyl (1996) (0)
Pharmacokinetics and pharmacodynamics of inhaled heroin: Relevance for treatment (2002) (0)
Measurements Instruments Scales Tests: CAGE-AID Screening for Substance Abuse Among Adolescents Validity of the CAGE-AID in Youth Mental Health Care (2009) (0)
Safety of nalmefene for the treatment of alcohol use disorder: an update (2019) (0)
EFQM quality assessment of institutions for addiction treatment (2002) (0)
Knowledge of and attitudes about drug addicts and their treatment among psychiatrists in Hungary (in Polish) (2007) (0)
[Recommendations for the screening, diagnosis and treatment of patients with comorbid attention deficit hyperactivity- and substance use disorder]. (2020) (0)
Cue-reactivity and craving in heroin dependent patients: a neuroimaging study using both SPECT and fMRI (2003) (0)
JS01-03 - Improved anti-addiction therapeutic programmes based on pharmacogenetic criteria (2011) (0)
Detection of bipolar disorders in patients with substance use disorders/validity of the mood disorder questionnaire in patients with substance use disorders (2005) (0)
The Unhealthy Chicken or the Unhealthy Egg: Quitting Smoking Matters: Response to Hajek et al. (2019) (0)
New treatment options for heroin dependent patients in the netherlands (2003) (0)
S.01.01 Neural mechanisms of pathological gambling: fMRI studies of the motivational and impulse control system (2012) (0)
Dr. Storosum and Colleagues Reply (2002) (0)
No difference in 5-HT transporter densities in individuals who stopped using MDMA as compared to controls (2000) (0)
Sodium Oxybate for Alcohol Dependence: A Network Meta-Regression Analysis Considering Population Severity at Baseline and Treatment Duration (2023) (0)
GL4 A RANDOMIZED TRIAL OF MEDICAL CO-PRESCRIPTION OF HEROIN TO CHRONIC, TREATMENT-RESISTANT HEROIN ADDICTS IN THE NETHERLANDS: DATA ON QALY'S (2003) (0)
Fischer et al. Respond. (2017) (0)
P.3.016 Incentive processing, psychopathic traits and persistent disruptive behavior: preliminary results of an fMRI study (2014) (0)
P.4.02 Effects of varenicline on dopamine D2/3 receptor binding in rats using ex vivo phosphor storage imaging (2009) (0)

This paper list is powered by the following services:

Other Resources About Wim van den Brink

en.wikipedia.org

What Schools Are Affiliated With Wim van den Brink?

Wim van den Brink is affiliated with the following schools:

Wim van den Brink's Academic­Influence.com Rankings